Infections in vasculitis

被引:39
作者
Guillevin, Loic [1 ]
机构
[1] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Dept Internal Med, F-75679 Paris, France
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2013年 / 27卷 / 01期
关键词
Vasculitis; Infections; Vaccination; Prophylaxis; HEPATITIS-B-VIRUS; CHURG-STRAUSS-SYNDROME; PNEUMOCYSTIS-CARINII-PNEUMONIA; MIXED CRYOGLOBULINEMIA VASCULITIS; TERM-FOLLOW-UP; POLYARTERITIS-NODOSA; RANDOMIZED-TRIAL; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; EXTRAHEPATIC MANIFESTATIONS;
D O I
10.1016/j.berh.2013.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infections, mainly viral, are the cause of some vasculitides, like polyarteritis nodosa (hepatitis B virus) or mixed cryoglobulinemia (hepatitis C virus), and it has been hypothesized that others might be due to infectious agents (HIV, EBV, parvovirus...). Among etiologies of vasculitis, the responsibility of a Burkholderia-like strain has been recently demonstrated as the cause of giant-cell arteritis. On the other hand, patients frequently develop infections, mainly as a consequence of steroids, immunosuppressants and most immunomodulating treatments prescribed to treat vasculitides. Infections occur when patients receive steroids and immunosuppressants, especially in the long term. They are more frequently observed in elderly patients or in patients with poor general condition. Infection risk is not reduced when biotherapies are prescribed to induce or maintain remission. Patients, considered at higher risk for infections, should be followed closely and their immunological status monitored periodically. We recommend especially to monitor neutrophiles, lymphocytes and if needed CD3-, CD4- and CD8-cell counts in patients receiving steroids and cyclophosphamide or other cytotoxic agents. In patients treated with rituximab, CD19 and gammaglobulins should be monitored regularly. Prophylaxis are needed in patients at risk to develop infections. (C) 2013 Published by Elsevier Ltd.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 90 条
[1]   Protective effect of A/H1N1 vaccination in immune-mediated disease-a prospectively controlled vaccination study [J].
Adler, Sabine ;
Krivine, Anne ;
Weix, Janine ;
Rozenberg, Flore ;
Launay, Odile ;
Huesler, Juerg ;
Guillevin, Loic ;
Villiger, Peter M. .
RHEUMATOLOGY, 2012, 51 (04) :695-700
[2]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[3]   Lamivudine in the treatment of hepatitis B virus-related polyarteritis Nodosa [J].
Auguet, Teresa ;
Barragan, Patricia ;
Ramirez, Rafael ;
Quer, Joan Carles ;
Sirvent, Joan Josep ;
Richart, Cristobal .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (05) :298-299
[4]   Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides:: an open pilot study on 10 patients [J].
Bartolucci, P ;
Ramanoelina, J ;
Cohen, P ;
Mahr, A ;
Godmer, P ;
Le Hello, C ;
Guillevin, L .
RHEUMATOLOGY, 2002, 41 (10) :1126-1132
[5]   Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient [J].
Bilge, I ;
Sadikoglu, B ;
Emre, S ;
Sirin, A ;
Aydin, K ;
Tatli, B .
PEDIATRIC NEPHROLOGY, 2005, 20 (04) :529-533
[6]   Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis [J].
Booth, A ;
Harper, L ;
Hammad, T ;
Bacon, P ;
Griffith, M ;
Levy, J ;
Savage, C ;
Pusey, C ;
Jayne, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (03) :717-721
[7]   Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome - A retrospective analysis of causes and factors predictive of mortality based on 595 patients [J].
Bourgarit, A ;
Le Toumelin, P ;
Pagnoux, C ;
Cohen, P ;
Mahr, AF ;
Le Guern, VR ;
Mouthon, L ;
Guillevin, L .
MEDICINE, 2005, 84 (05) :323-330
[8]   Extrahepatic manifestations associated with hepatitis C virus infection - A prospective multicenter study of 321 patients [J].
Cacoub, P ;
Renou, C ;
Rosenthal, E ;
Cohen, P ;
Loury, I ;
Loustaud-Ratti, V ;
Yamamoto, AM ;
Camproux, AC ;
Hausfater, P ;
Musset, L ;
Veyssier, P ;
Raguin, G ;
Piette, JC .
MEDICINE, 2000, 79 (01) :47-56
[9]   POLYARTERITIS-NODOSA AND HEPATITIS-C VIRUS-INFECTION [J].
CACOUB, P ;
LUNELFABIANI, F ;
DU, LTH .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :605-606
[10]   Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection [J].
Casato, M ;
Agnello, V ;
Pucillo, LP ;
Knight, GB ;
Leoni, M ;
DelVecchio, S ;
Mazzilli, C ;
Antonelli, G ;
Bonomo, L .
BLOOD, 1997, 90 (10) :3865-3873